Brevan Howard Capital Management LP Bio N Tech Se Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Bio N Tech Se stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 7,064 shares of BNTX stock, worth $728,227. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,064Holding current value
$728,227% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
318Shares Held
43.6MCall Options Held
1.15MPut Options Held
1.36M-
Baillie Gifford & CO7.88MShares$812 Million0.61% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.83MShares$498 Million0.29% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$436 Million1.69% of portfolio
-
Primecap Management CO Pasadena, CA3.87MShares$399 Million0.3% of portfolio
-
Dodge & Cox San Francisco, CA3.65MShares$376 Million0.21% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...